Skip to main content
. 2013 Feb 13;21(6):703–714. doi: 10.1007/s12282-013-0444-8

Table 4.

Treatment-emergent adverse events with at least 10 % incidence in the everolimus + exemestane arm in the Asian and non-Asian subpopulations

graphic file with name 12282_2013_444_Tab4a_HTML.jpg

graphic file with name 12282_2013_444_Tab4b_HTML.jpg

ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyltransferase, ILD interstitial lung disease, LDH lactate dehydrogenase